$1.54 Billion is the total value of Eventide Asset Management's 128 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 15.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $58,824,000 | -1.4% | 720,000 | +0.5% | 3.83% | +5.1% |
| ABBV | Buy | ABBVIE INC | $52,626,000 | -0.1% | 840,400 | +0.6% | 3.42% | +6.5% |
| XPO | Sell | XPO LOGISTICS INC | $48,771,000 | -6.3% | 1,130,000 | -20.4% | 3.17% | -0.2% |
| LEA | Sell | LEAR CORP | $46,330,000 | -12.9% | 350,000 | -20.3% | 3.01% | -7.2% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $40,589,000 | -23.8% | 810,000 | -20.2% | 2.64% | -18.8% |
| LOW | Sell | LOWES COS INC | $40,183,000 | -10.2% | 565,000 | -8.9% | 2.61% | -4.4% |
| KAR | KAR AUCTION SVCS INC | $38,358,000 | -1.3% | 900,000 | 0.0% | 2.50% | +5.3% | |
| BLUE | Buy | BLUEBIRD BIO INC | $36,260,000 | -0.8% | 587,677 | +8.9% | 2.36% | +5.7% |
| IPHI | INPHI CORP | $35,656,000 | +2.6% | 799,100 | 0.0% | 2.32% | +9.3% | |
| CELG | Sell | CELGENE CORP | $35,338,000 | -28.9% | 305,300 | -35.8% | 2.30% | -24.2% |
| LRCX | Sell | LAM RESEARCH CORP | $34,838,000 | -25.3% | 329,500 | -33.0% | 2.27% | -20.3% |
| STLD | Sell | STEEL DYNAMICS INC | $33,801,000 | +6.1% | 950,000 | -25.5% | 2.20% | +13.1% |
| MBBYF | MOBILEYE N V AMSTELVEEN | $33,309,000 | -10.5% | 873,800 | 0.0% | 2.17% | -4.6% | |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $32,351,000 | -16.4% | 2,077,751 | +3.4% | 2.10% | -11.0% |
| MGA | Sell | MAGNA INTL INC | $32,129,000 | +0.0% | 740,300 | -1.0% | 2.09% | +6.6% |
| SGEN | Sell | SEATTLE GENETICS INC | $29,551,000 | -34.5% | 560,000 | -33.0% | 1.92% | -30.2% |
| CRUS | CIRRUS LOGIC INC | $28,270,000 | +6.4% | 500,000 | 0.0% | 1.84% | +13.4% | |
| SNA | Buy | SNAP ON INC | $27,403,000 | +100.4% | 160,000 | +77.8% | 1.78% | +113.5% |
| PFPT | PROOFPOINT INC | $27,200,000 | -5.6% | 385,000 | 0.0% | 1.77% | +0.6% | |
| WBC | WABCO HLDGS INC | $27,132,000 | -6.5% | 255,600 | 0.0% | 1.76% | -0.4% | |
| STKL | SUNOPTA INC | $27,020,000 | -0.1% | 3,832,600 | 0.0% | 1.76% | +6.4% | |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $26,578,000 | -7.8% | 306,300 | +0.1% | 1.73% | -1.7% |
| SPLK | SPLUNK INC | $25,575,000 | -12.8% | 500,000 | 0.0% | 1.66% | -7.1% | |
| CYBR | CYBERARK SOFTWARE LTD | $25,025,000 | -8.2% | 550,000 | 0.0% | 1.63% | -2.2% | |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $24,660,000 | +2.0% | 1,046,700 | 0.0% | 1.60% | +8.7% | |
| LOXO | LOXO ONCOLOGY INC | $23,765,000 | +22.7% | 740,000 | 0.0% | 1.55% | +30.7% | |
| AYI | Buy | ACUITY BRANDS INC | $23,086,000 | +9.1% | 100,000 | +25.0% | 1.50% | +16.3% |
| ASML | ASML HOLDING N V | $22,440,000 | +2.4% | 200,000 | 0.0% | 1.46% | +9.1% | |
| ATHN | ATHENAHEALTH INC | $21,160,000 | -16.6% | 201,200 | 0.0% | 1.38% | -11.1% | |
| ARW | ARROW ELECTRS INC | $21,034,000 | +11.5% | 295,000 | 0.0% | 1.37% | +18.8% | |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $20,167,000 | -4.2% | 1,553,700 | +6.2% | 1.31% | +2.0% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $20,151,000 | +4.7% | 789,000 | +14.7% | 1.31% | +11.6% |
| ROL | Buy | ROLLINS INC | $19,930,000 | +38.9% | 590,000 | +20.4% | 1.30% | +48.1% |
| DOOR | Buy | MASONITE INTL CORP NEW | $19,823,000 | +57.3% | 301,260 | +48.6% | 1.29% | +67.8% |
| VCYT | VERACYTE INC | $17,430,000 | +1.7% | 2,252,000 | 0.0% | 1.13% | +8.4% | |
| BWA | BORGWARNER INC | $17,354,000 | +12.1% | 440,000 | 0.0% | 1.13% | +19.5% | |
| AY | Sell | ATLANTICA YIELD PLC | $17,318,000 | -0.3% | 895,000 | -2.0% | 1.13% | +6.3% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $16,730,000 | -15.5% | 881,000 | +0.1% | 1.09% | -9.9% |
| MGNX | MACROGENICS INC | $14,835,000 | -31.7% | 725,800 | 0.0% | 0.96% | -27.2% | |
| WCN | New | WASTE CONNECTIONS INC | $13,753,000 | – | 175,000 | +100.0% | 0.90% | – |
| WSO | WATSCO INC | $13,331,000 | +5.1% | 90,000 | 0.0% | 0.87% | +12.0% | |
| WAB | Sell | WABTEC CORP | $13,283,000 | -53.5% | 160,000 | -54.3% | 0.86% | -50.5% |
| PANW | Sell | PALO ALTO NETWORKS INC | $13,130,000 | -59.8% | 105,000 | -48.8% | 0.85% | -57.2% |
| INST | New | INSTRUCTURE INC | $13,099,000 | – | 670,000 | +100.0% | 0.85% | – |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $13,084,000 | +5.1% | 689,000 | +29.3% | 0.85% | +12.0% |
| AGIO | AGIOS PHARMACEUTICALS INC | $12,552,000 | -21.0% | 300,800 | 0.0% | 0.82% | -15.8% | |
| W | New | WAYFAIR INCcl a | $12,268,000 | – | 350,000 | +100.0% | 0.80% | – |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $11,236,000 | +2.1% | 445,000 | 0.0% | 0.73% | +8.8% | |
| XLRN | ACCELERON PHARMA INC | $10,946,000 | -29.5% | 428,900 | 0.0% | 0.71% | -24.9% | |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $10,032,000 | -18.7% | 383,630 | +1.0% | 0.65% | -13.3% |
| ACAD | ACADIA PHARMACEUTICALS INC | $9,653,000 | -9.3% | 334,700 | 0.0% | 0.63% | -3.4% | |
| STML | STEMLINE THERAPEUTICS INC | $9,110,000 | -1.2% | 851,400 | 0.0% | 0.59% | +5.3% | |
| XNCR | XENCOR INC | $9,054,000 | +7.5% | 344,000 | 0.0% | 0.59% | +14.6% | |
| AYR | AIRCASTLE LTD | $8,936,000 | +5.0% | 428,600 | 0.0% | 0.58% | +11.7% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $8,768,000 | -3.3% | 249,600 | 0.0% | 0.57% | +2.9% | |
| TSRO | Sell | TESARO INC | $8,741,000 | +16.3% | 65,000 | -13.3% | 0.57% | +24.0% |
| SAGE | SAGE THERAPEUTICS INC | $8,680,000 | +10.9% | 170,000 | 0.0% | 0.56% | +18.2% | |
| TSLA | TESLA MTRS INC | $8,548,000 | +4.7% | 40,000 | 0.0% | 0.56% | +11.6% | |
| ONCE | SPARK THERAPEUTICS INC | $7,485,000 | -16.9% | 150,000 | 0.0% | 0.49% | -11.5% | |
| BPMC | BLUEPRINT MEDICINES CORP | $7,433,000 | -5.6% | 265,000 | 0.0% | 0.48% | +0.6% | |
| GWPH | GW PHARMACEUTICALS PLCads | $7,096,000 | -15.8% | 63,500 | 0.0% | 0.46% | -10.3% | |
| EXR | Buy | EXTRA SPACE STORAGE INC | $6,295,000 | -0.9% | 81,500 | +1.9% | 0.41% | +5.7% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,213,000 | -10.5% | 75,000 | 0.0% | 0.40% | -4.7% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $6,145,000 | -0.9% | 87,400 | 0.0% | 0.40% | +5.5% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $5,971,000 | +66.6% | 220,000 | +57.1% | 0.39% | +77.2% |
| PRTA | PROTHENA CORP PLC | $5,903,000 | -18.0% | 120,000 | 0.0% | 0.38% | -12.5% | |
| CSLT | Sell | CASTLIGHT HEALTH INCcl b | $5,792,000 | -18.5% | 1,170,000 | -31.5% | 0.38% | -13.1% |
| KITE | Sell | KITE PHARMA INC | $5,740,000 | -30.9% | 128,000 | -13.9% | 0.37% | -26.4% |
| ESSA PHARMA INC | $5,265,000 | -22.9% | 2,719,410 | 0.0% | 0.34% | -17.7% | ||
| CERN | CERNER CORP | $5,125,000 | -23.3% | 108,200 | 0.0% | 0.33% | -18.4% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $4,838,000 | -23.6% | 125,000 | 0.0% | 0.32% | -18.4% | |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $4,635,000 | – | 229,000 | +100.0% | 0.30% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $4,472,000 | – | 215,000 | +100.0% | 0.29% | – |
| TCON | Buy | TRACON PHARMACEUTICALS INC | $4,241,000 | +21.2% | 865,526 | +67.2% | 0.28% | +29.0% |
| BOLD | AUDENTES THERAPEUTICS INC | $4,111,000 | +2.6% | 225,000 | 0.0% | 0.27% | +9.0% | |
| CHRS | COHERUS BIOSCIENCES INC | $4,082,000 | +5.1% | 145,000 | 0.0% | 0.27% | +12.2% | |
| INCY | INCYTE CORP | $4,011,000 | +6.3% | 40,000 | 0.0% | 0.26% | +13.5% | |
| VYGR | VOYAGER THERAPEUTICS INC | $3,822,000 | +6.1% | 300,000 | 0.0% | 0.25% | +13.2% | |
| ATRC | ATRICURE INC | $3,523,000 | +23.7% | 180,000 | 0.0% | 0.23% | +31.6% | |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $3,405,000 | – | 250,000 | +100.0% | 0.22% | – |
| RGEN | REPLIGEN CORP | $3,390,000 | +2.1% | 110,000 | 0.0% | 0.22% | +8.9% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $3,370,000 | -44.8% | 90,000 | 0.0% | 0.22% | -41.1% | |
| GLPG | GALAPAGOS NVspon adr | $3,338,000 | -0.7% | 52,000 | 0.0% | 0.22% | +5.9% | |
| EPZM | EPIZYME INC | $3,328,000 | +23.0% | 275,000 | 0.0% | 0.22% | +31.5% | |
| HRTX | New | HERON THERAPEUTICS INC | $2,948,000 | – | 225,000 | +100.0% | 0.19% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $2,889,000 | – | 175,000 | +100.0% | 0.19% | – |
| CDTX | CIDARA THERAPEUTICS INC | $2,746,000 | -9.2% | 264,000 | 0.0% | 0.18% | -3.2% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $2,697,000 | -21.4% | 220,000 | 0.0% | 0.18% | -16.3% | |
| NTUS | NATUS MEDICAL INC DEL | $2,610,000 | -11.4% | 75,000 | 0.0% | 0.17% | -5.6% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $2,610,000 | -4.4% | 279,100 | 0.0% | 0.17% | +1.8% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $2,549,000 | -15.5% | 34,600 | 0.0% | 0.17% | -9.8% | |
| TGTX | TG THERAPEUTICS INC | $2,500,000 | -39.9% | 537,600 | 0.0% | 0.16% | -35.8% | |
| TTPH | TETRAPHASE PHARMACEUTICALS I | $2,418,000 | +5.2% | 600,000 | 0.0% | 0.16% | +12.1% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $2,384,000 | -37.3% | 165,000 | 0.0% | 0.16% | -33.2% | |
| SYRS | SYROS PHARMACEUTICALS INC | $1,824,000 | -12.3% | 150,000 | 0.0% | 0.12% | -6.3% | |
| NVAX | Sell | NOVAVAX INC | $1,827,000 | -59.7% | 1,449,700 | -33.5% | 0.12% | -57.0% |
| JUNO | JUNO THERAPEUTICS INC | $1,697,000 | -37.2% | 90,000 | 0.0% | 0.11% | -33.3% | |
| CTMX | CYTOMX THERAPEUTICS INC | $1,649,000 | -29.9% | 150,000 | 0.0% | 0.11% | -25.7% | |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $1,604,000 | +14.7% | 35,000 | +9.4% | 0.10% | +22.4% |
| HTGC | Buy | HERCULES CAPITAL INC | $1,496,000 | +39.7% | 106,000 | +34.2% | 0.10% | +49.2% |
| TIG | New | TIGENIXsponsored ads | $1,458,000 | – | 100,000 | +100.0% | 0.10% | – |
| OMED | ONCOMED PHARMACEUTICALS INC | $1,465,000 | -32.6% | 190,000 | 0.0% | 0.10% | -28.6% | |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $1,411,000 | +31.0% | 47,500 | +35.7% | 0.09% | +39.4% |
| ARAY | ACCURAY INC | $1,409,000 | -27.7% | 306,200 | 0.0% | 0.09% | -22.7% | |
| JCI | Buy | JOHNSON CTLS INTL PLC | $1,227,000 | +1.4% | 29,800 | +14.6% | 0.08% | +8.1% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,107,000 | +16.8% | 38,500 | +24.2% | 0.07% | +24.1% |
| DRNA | DICERNA PHARMACEUTICALS INC | $1,086,000 | -51.0% | 377,000 | 0.0% | 0.07% | -47.4% | |
| HMC | Buy | HONDA MOTOR LTD | $1,065,000 | +16.9% | 36,500 | +15.9% | 0.07% | +23.2% |
| NYLD | Buy | NRG YIELD INCcl c | $1,027,000 | +0.9% | 65,000 | +8.3% | 0.07% | +8.1% |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,024,000 | +12.0% | 62,000 | +6.0% | 0.07% | +19.6% |
| ABB | Buy | ABB LTDsponsored adr | $895,000 | +49.9% | 42,500 | +60.4% | 0.06% | +61.1% |
| CPPL | Sell | COLUMBIA PIPELINE PARTNERS L | $772,000 | -24.1% | 45,000 | -28.6% | 0.05% | -19.4% |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $618,000 | +69.3% | 12,900 | +61.2% | 0.04% | +81.8% |
| TNDM | TANDEM DIABETES CARE INC | $591,000 | -72.0% | 275,000 | 0.0% | 0.04% | -70.5% | |
| BG | Sell | BUNGE LIMITED | $556,000 | +10.5% | 7,700 | -9.4% | 0.04% | +16.1% |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $510,000 | +23.8% | 12,900 | +26.5% | 0.03% | +32.0% |
| LXP | Buy | LEXINGTON REALTY TRUST | $443,000 | +30.3% | 41,000 | +24.2% | 0.03% | +38.1% |
| ETN | EATON CORP PLC | $436,000 | +2.1% | 6,500 | 0.0% | 0.03% | +7.7% | |
| FHB | Sell | FIRST HAWAIIAN INC | $400,000 | +19.0% | 11,500 | -8.0% | 0.03% | +23.8% |
| BIP | New | BROOKFIELD INFRAST PARTNERSlp int unit | $384,000 | – | 11,462 | +100.0% | 0.02% | – |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $387,000 | +10.6% | 16,500 | +7.1% | 0.02% | +19.0% |
| VTR | New | VENTAS INC | $375,000 | – | 6,000 | +100.0% | 0.02% | – |
| WELL | Buy | WELLTOWER INC | $335,000 | +24.5% | 5,000 | +38.9% | 0.02% | +37.5% |
| BBN | Buy | BLACKROCK TAX MUNICPAL BD TR | $302,000 | -6.2% | 14,000 | +4.1% | 0.02% | 0.0% |
| NSC | Sell | NORFOLK SOUTHERN CORP | $292,000 | +0.3% | 2,700 | -10.0% | 0.02% | +5.6% |
| ERIC | Buy | ERICSSONadr b sek 10 | $280,000 | -15.7% | 48,000 | +4.3% | 0.02% | -10.0% |
| GLBL | Sell | TERRAFORM GLOBAL INCcl a | $221,000 | -10.5% | 56,000 | -6.7% | 0.01% | -6.7% |
| ZSAN | Sell | ZOSANO PHARMA CORP | $212,000 | -68.6% | 272,000 | -69.4% | 0.01% | -65.9% |
| TERP | Exit | TERRAFORM PWR INC | $0 | – | -15,500 | -100.0% | -0.01% | – |
| ODFL | Exit | OLD DOMINION FGHT LINES INC | $0 | – | -15,000 | -100.0% | -0.06% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -180,000 | -100.0% | -0.08% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -178,200 | -100.0% | -0.13% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -250,000 | -100.0% | -0.16% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -184,900 | -100.0% | -0.27% | – |
| CPN | Exit | CALPINE CORP | $0 | – | -500,000 | -100.0% | -0.39% | – |
| ORA | Exit | ORMAT TECHNOLOGIES INC | $0 | – | -276,959 | -100.0% | -0.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.